Peter Bou Dib: New Insights on Factor VIII and the Musculoskeletal System
Peter Bou Dib, Key Account Manager at Sino Biological Europe, shared on LinkedIn about a recent article by Antoine Babuty et al, published in Nature Bone Research:
”Hemophilia A (HA) has long been known as a bleeding disorder caused by deficient Factor VIII (FVIII), leading to life-impacting joint bleeds and muscle degeneration.
But what if FVIII’s role extends far beyond just stopping bleeds?
A recently published study using FVIII knockout mice uncovered a surprising story: FVIII deficiency triggers early osteoporosis, disrupted bone vascularization, and muscle abnormalities
a complex musculoskeletal disruption that mirrors patients’ real-life challenges.
Even more promising, intravenous recombinant FVIII treatment not only restored bone density and vascular health but partially reversed muscle metabolic defects.
This suggests FVIII acts as a critical regulator of bone remodeling and muscle metabolism, not just coagulation.
For those living with HA, these insights kindle hope for therapies that protect bones and muscles, improving quality of life beyond bleeding control.
Science is rewriting what we know about FVIII, transforming how we understand, treat, and support hemophilia.
The journey continues.”
Title: Factor VIII restores bone parameters and modulates muscle proteo-metabolome in Factor VIII knockout male mice
Authors: Antoine Babuty, Javier Muñoz-Garcia, Olivier D. Christophe, Laurie Fradet, Manon Taupin, Denis Cochonneau, Emilie Ollivier, Frank Driessler, Claudia Lange, Oleksandr Boychenko, Marie-Françoise Heymann, Dominique Heymann
Read the Full Article on Nature Bone Research
Stay updated on all scientific advances with Hemostasis Today.
-
May 1, 2026, 17:55Salih Ehsan: The Deceptive Nature of B12 Deficiency Not Just Anemia
-
May 1, 2026, 17:45Angela Blue: Insurance Education as a Tool for Strengthening Patient Communities
-
May 1, 2026, 17:36Smitirupa Mishra: Hematology Formulas Made Simple, Structured, And Useful For Everyday Clinical Practice
-
May 1, 2026, 17:00Frank Weinz: VTE Prevention Strategies and Advances in Clinical Practice
-
May 1, 2026, 16:54Pierre François Sabouret: Women’s Health Should Be a Priority for All HCPs, Not Just WIC
-
May 1, 2026, 16:44Jean Jacques Kiladjian: A Global Triumph in MPN Research at ESHMPN 2026
-
May 1, 2026, 16:36Shek Sady Khan: VTE as a Major Yet Underrecognized Cause of Preventable Morbidity and Mortality
-
May 1, 2026, 16:11Anu Thomas: History of Blood Transfusion
-
May 1, 2026, 16:01A 100-Study Systematic Review Reevaluates PT and aPTT Testing in Perioperative Bleeding – JTH